Background Survivors of critical illness often experience poor outcomes after hospitalisation, including delayed return to work, which carries substantial economic consequences.
Objective To conduct a systematic review and meta-analysis of return to work after critical illness.
Methods We searched PubMed, Embase, PsycINFO, CINAHL and Cochrane Library from 1970 to February 2018. Data were extracted, in duplicate, and random-effects meta-regression used to obtain pooled estimates.
Results Fifty-two studies evaluated return to work in 10 015 previously employed survivors of critical illness, over a median (IQR) follow-up of 12 (6.25–38.5) months. By 1–3, 12 and 42–60 months’ follow-up, pooled return to work prevalence (95% CI) was 36% (23% to 49%), 60% (50% to 69%) and 68% (51% to 85%), respectively (τ 2=0.55, I2=87%, p=0.03). No significant difference was observed based on diagnosis (acute respiratory distress syndrome (ARDS) vs non-ARDS) or region (Europe vs North America vs Australia/New Zealand), but was observed when comparing mode of employment evaluation (in-person vs telephone vs mail). Following return to work, 20%–36% of survivors experienced job loss, 17%–66% occupation change and 5%–84% worsening employment status (eg, fewer work hours). Potential risk factors for delayed return to work include pre-existing comorbidities and post-hospital impairments (eg, mental health).
Conclusion Approximately two-thirds, two-fifths and one-third of previously employed intensive care unit survivors are jobless up to 3, 12 and 60 months following hospital discharge. Survivors returning to work often experience job loss, occupation change or worse employment status. Interventions should be designed and evaluated to reduce the burden of this common and important problem for survivors of critical illness.
Trial registration number PROSPERO CRD42018093135.
- critical care
- clinical epidemiology
Statistics from Altmetric.com
Contributors Conception and design: BBK, MRS, DMN, RH. Analysis and interpretation: BBK, RS, MRS, KFD, KDS, EC, VDD, DMN, RH. Drafting the manuscript for important intellectual content: BBK, MRS, DMN, RH. Final approval of the version to be published: BBK, RS, MRS, KFD, KDS, EC, VDD, DMN, RH.
Funding BBK is supported by a Paul B Beeson Career Development Award through the National Institutes of Health/National Institute on Aging (K76AG059936). DMN is supported by funding from the National Institutes of Health/National Heart, Lung, and Blood Institute (R24HL111985). BBK had full access to the data and final responsibility for the decision to submit this study for publication.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on reasonable request.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.